Table 3.
Blood profile of STZ-induced diabetes after one-month treatment.
| Parameter | Unit | Group | ||
|---|---|---|---|---|
| Control | STZ | FRB | ||
| Total protein | g/dL | 6.97 ± 0.51 a | 5.62 ± 0.38 b | 5.98 ± 0.72 b |
| Albumin | g/dL | 4.58 ± 0.35 a | 3.62 ± 0.22 b | 3.68 ± 0.45 b |
| Amylase | IU/L | 2308.33 ± 204 a | 1045.50 ± 326 b | 1329.00 ± 399 b |
| Triglyceride | mg/dL | 359.50 ± 139 a | 69.17 ± 30.2 b | 130.00 ± 101 b |
| HDL-cholesterol | mg/dL | 33.17 ± 3.25 a | 43.67 ± 8.66 b | 44.40 ± 10.30 b |
| Glucose | mg/dL | 153.83 ± 11.36 a | 680.00 ± 125.65 b | 614.00 ± 68.7 b |
| Insulin | ng/mL | 4.42 ± 0.99 a | 0.44 ± 0.13 b | 0.51 ± 0.29 b |
STZ: streptozotocin, FRB: fermented rice bran, HDL: high-density lipoprotein. Data are shown as the means ± SEM and were analyzed using ANOVA followed by Tukey’s post hoc test. Significance (p < 0.05, n = 5–6) among groups is denoted by different letters (a, b).